SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 6.37 |
Enterprise Value ($M) | 1.52 |
Book Value ($M) | 3.06 |
Book Value / Share | 0.27 |
Price / Book | 2.08 |
NCAV ($M) | -1.25 |
NCAV / Share | -0.11 |
Price / NCAV | -5.11 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -3.22 |
Return on Assets (ROA) | -1.08 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.85 |
Current Ratio | 0.85 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5.98 |
Assets | 10.28 |
Liabilities | 7.22 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 5.44 |
Operating Income | -15.72 |
Net Income | -14.10 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -16.21 |
Cash from Investing | 0.33 |
Cash from Financing | 8.47 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Bartoszek Raymond J. | 16.20 | 103.25 | |
13G | Armistice Capital, Llc | 9.99 | ||
13D/A | Iadonato Shawn | 9.70 | 15.99 | |
13G/A | Magness Charles | 6.10 | -1.12 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
24,007 | 67,152 | 35.75 | |
7,389 | 8,849 | 83.50 | |
21,062 | 12,440 | 169.31 | |
19,356 | 9,266 | 208.89 | |
(click for more detail) |
Similar Companies | |
---|---|
JAGX – Jaguar Health, Inc. | JAN – JanOne Inc. |
JSPR – Jasper Therapeutics, Inc. | KALA – KALA BIO, Inc. |
KPRX – Kiora Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io